Norgestrel 0.075 mg tablets: Clinical Trials

2 trials of Norgestrel 0.075 mg tablets, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Terminated 1

Follow Norgestrel 0.075 mg tablets: new trials by email Literature Review of Norgestrel 0.075 mg tablets trials Research Report on Norgestrel 0.075 mg tablets

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use
Norgestrel 0.075 mg tablets - Contraception
Phase 3CompletedHRA Pharma9622019-09-062022-05-20
A Study of Oral Contraception Under Simulated OTC Conditions
Norgestrel 0.075 mg tablets - Contraception
Phase 3TerminatedHRA Pharma1892018-04-272022-04-04

Sponsors

HRA Pharma (2)

Countries

United States (2)

Top investigators

Russ Bradford, MD, MSPH (1)  ·  Russell Bradford, MD, MSPH (1)